Cytek Biosciences Files 8-K on Financials
Ticker: CTKB · Form: 8-K · Filed: Mar 1, 2024 · CIK: 1831915
| Field | Detail |
|---|---|
| Company | Cytek Biosciences, Inc. (CTKB) |
| Form Type | 8-K |
| Filed Date | Mar 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
Related Tickers: CYTK
TL;DR
CYTK dropped an 8-K on Feb 28th detailing financial results. Check it out.
AI Summary
Cytek Biosciences, Inc. filed an 8-K on March 1, 2024, reporting results of operations and financial condition as of February 28, 2024. The filing details financial statements and exhibits related to the company's performance.
Why It Matters
This 8-K filing provides investors with crucial updates on Cytek Biosciences' financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not inherently introduce new risks.
Key Players & Entities
- Cytek Biosciences, Inc. (company) — Registrant
- 001-40632 (company) — SEC File Number
- 47-2547526 (company) — IRS Employer Identification No.
- February 28, 2024 (date) — Date of earliest event reported
- March 1, 2024 (date) — Date of Report
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported was on February 28, 2024.
What is the company's principal executive office address?
The address is 47215 Lakeview Boulevard, Fremont, California, 94538.
What is Cytek Biosciences, Inc.'s IRS Employer Identification Number?
The IRS Employer Identification Number is 47-2547526.
What is the SEC file number for Cytek Biosciences, Inc.?
The SEC file number is 001-40632.
Filing Stats: 524 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-03-01 06:06:02
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share CTKB Nasdaq Global Select
Filing Documents
- d781057d8k.htm (8-K) — 25KB
- d781057dex991.htm (EX-99.1) — 118KB
- d781057dex992.htm (EX-99.2) — 78KB
- g781057snap1.jpg (GRAPHIC) — 1KB
- 0001193125-24-054312.txt ( ) — 369KB
- ctkb-20240228.xsd (EX-101.SCH) — 3KB
- ctkb-20240228_lab.xml (EX-101.LAB) — 17KB
- ctkb-20240228_pre.xml (EX-101.PRE) — 11KB
- d781057d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description of Exhibit 99.1 Press release dated February 28, 2024 99.2 Transcript of conference call held on February 28, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cytek Biosciences, Inc. Date: March 1, 2024 By: /s/ Wenbin Jiang, Ph.D. Wenbin Jiang, Ph.D. President and Chief Executive Officer